Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PTG-200 in Normal Healthy Male Volunteers

Next Previous
X
Search
Trial Profile

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PTG-200 in Normal Healthy Male Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2019

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PTG 200 (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions; First in man
  • Acronyms PTG-200-01
  • Sponsors Protagonist Therapeutics

    • Most Recent Events

    • 06 Nov 2019 According to a Protagonist Therapeutics media release, data from the study were recently presented at the United European Gastroenterology Week conference and the American College of Gastroenterology (ACG) Annual Scientific Meeting.
    • 01 Oct 2019 According to a Protagonist Therapeutics media release, data from the study will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting 2019.
    • 01 Oct 2019 According to a Protagonist Therapeutics media release, data from the study will be presented at the UEG Week 2019 Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top